Arca
Skip to content
Tools
Tools

Coagusense Self-Test Prothrombin Time/Inr Monitoring System

Test, Time, Prothrombin. 510(k) K093243, from Coagusense, Inc. (Fremont, CA). Product code GJS, class 2.

As of Nov 18, 2026, K093243 is an FDA 510(k) held by Coagusense, Inc., substantially equivalent on Apr 7, 2010 after 174 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 174 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The CoaguSense Self-Test PT Monitoring System is an in vitro diagnostic device that provides quantitative prothrombin time (PT) results, expressed in seconds and international normalized ratio (INR) units. It uses fresh capillary whole blood. It is intended for use by properly selected and suitably trained patients or their caregivers on the order of the treating doctor.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K093243, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
May 25, 2022Z-1583-2022Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.Open

Other GJS clearances

The newest 510(k)s for the same product code; their median review was 299 days; see every GJS device

Record

Type
Traditional
Received
Oct 15, 2009
Review panel
Hematology
Regulation
21 CFR 864.7750

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.